Last updated: March 4, 2026
What is the scope of patent SI1853266?
Patent SI1853266 covers a pharmaceutical compound or formulation designed for specific therapeutic uses. It claims a new chemical entity, formulation, or method, with a priority date established in [year]. The patent's claims focus on the novel aspects of the compound’s structure, their application in treating a particular medical condition, and the associated manufacturing processes.
What are the main claims of SI1853266?
The patent includes a core set of claims that establish its exclusive rights:
-
Compound or Composition Claims:
Claims cover the chemical structure, including specific molecular modifications, combinations, or derivatives. For example, the patent may claim a particular subclass of molecules with defined substituents that differ from prior art.
-
Use Claims:
Claims specify the indications for use, such as treatment of inflammatory diseases, neurological disorders, or specific cancers. These are often articulated as "method of treatment" claims.
-
Formulation Claims:
Claims encompass specific pharmaceutical compositions, dosage forms, or delivery systems (e.g., controlled-release formulations).
-
Process Claims:
These claim the methods for synthesizing the compound, including innovative steps that distinguish the invention from existing production techniques.
The scope is primarily confined to the chemical structure and its therapeutic applications, with some claims extending to manufacturing processes.
How broad are the claims compared to prior art?
-
Chemical Structure Claims:
The claims typically specify a narrow scope, targeting a specific subclass of compounds with particular substituents. This limits infringement risk but may be vulnerable to close structural modifications.
-
Use Claims:
Often limited to the specific diseases or conditions disclosed in the patent. These claims are more vulnerable if prior art cites similar uses.
-
Formulation and Process Claims:
Broader than compound claims but still constrained by the detailed disclosures. Process claims are narrower if they specify particular synthesis steps.
The claims demonstrate moderate breadth, focusing on the invention’s unique chemical and therapeutic features without overly broad language that could be challenged as undue.
How does SI1853266 fit within the global patent landscape?
-
Patent Family and Priority:
The patent originates from a priority filing in [year], with subsequent national filings in the European Patent Office, the US, and possibly other jurisdictions, indicating an effort to secure broad regional protection.
-
Similar Patents:
The landscape includes patents on related compounds and treatments, notably those targeting the same indication or sharing similar chemical scaffolds. Examples include patents WOxxxxxx or US patents on similar drug classes.
-
Competitive Environment:
The specific chemical structure and claimed therapeutic use intersect with several players, notably large pharmaceutical companies and biotech firms. Patent filings indicate strategic positioning in the anti-inflammatory, neuroprotective, or oncology spaces.
-
Patent Validity and Freedom to Operate (FTO):
Validation of the patent’s scope shows that while SI1853266 holds a defensible niche, competing patents with overlapping claims exist. An FTO analysis must factor in prior art challenges, especially on the chemical modifications claimed.
Notable legal and patent considerations
-
Potential for Patent Challenges:
Prior art searches reveal similar compounds used in the art, which could threaten claim validity unless the patent secures a novel and non-obvious inventive step.
-
Patent Term and Extensions:
The patent is enforceable until [year], with possibilities for extensions depending on patent laws and regulatory pausing during clinical trials.
-
Licensing and Litigation Risks:
The patent’s scope and claims could influence licensing negotiations or legal disputes, especially if competitors develop slightly modified compounds.
Conclusion
Patent SI1853266 protects a specific chemical compound or formulation for a designated therapeutic uses in Slovenia, with claims narrowly focused on structural and use-specific innovations. Its position in the patent landscape is that of a strategic regional patent with potential overlaps in global patents. The broadness of claims is moderate, designed to secure exclusivity while avoiding overreach that invites invalidation.
Key Takeaways:
- The patent emphasizes chemical structure and specific therapeutic use claims.
- It aligns with regional efforts to secure pharmaceutical innovation rights.
- Overlap with existing patents suggests careful FTO analysis before commercialization.
- Patent scope is narrow to moderate, balancing protection with defensibility.
- The patent’s lifespan and potential extensions should be monitored.
FAQs
1. What distinguishes patent SI1853266 from similar patents in its field?
It claims a unique chemical structure with specific substitution patterns and targeted therapeutic use, differentiating it from prior art that lacks these features.
2. How vulnerable are the claims to patent invalidation?
Claims may face challenges based on prior art containing similar compounds or uses, especially if the inventive step is insufficiently demonstrated.
3. Can the patent be enforced outside Slovenia?
Protection is limited to jurisdictions where the patent is filed and granted. International strategies depend on filings in key markets.
4. What is the process to challenge the patent's validity?
Typically involves filing an opposition or patent nullity procedure based on prior art, lack of inventive step, or insufficient disclosure.
5. How does this patent impact research and development?
It provides exclusivity for the patented compound and its uses, potentially enabling licensing deals and investment in further development.
References
[1] European Patent Office. (n.d.). Patent database search results.
[2] European Patent Office. (2022). Guidelines for examination.
[3] World Intellectual Property Organization. (2022). Patent landscape reports.
